Cilnidipine西尼地平,132203-70-4

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Cilnidipine

CAS No. : 132203-70-4

MCE 国际站：Cilnidipine

产品活性：Cilnidipine 是一种长效的第二代二氢吡啶类 Ca²⁺ 通道阻断剂，可有效作用于 L 和 N 型 Ca²⁺ 通道。具有抗高血压作用。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling

作用靶点：Calcium Channel

In Vitro: Cilnidipine inhibits the L-type current with an IC₅₀ of 100 nM in neurons pretreated with omegaCgTx plus omegaAgTx.
The IC₅₀ for Cilnidipine in respect of the N-type current is 200 nM.
Cilnidipine dose- and time-dependently inhibits Ba²⁺ currents in A7r5 cells with the IC₅₀ at 10 nM after 10 min.
Cilnidipine dose-dependently inhibits depolarization- and Ca²⁺-induced contractions of rat aortic rings, with an IC₅₀ of 10 nM at 10 min.
The viability of nPC12 cells show no significant change up to 150 μM Cilnidipine, but it decreases slightly in the cells treated with greater than 200 μM Cilnidipine.
Cilnidipine (100 μM, 2 hours) treatment increases the expression of p85aPI3K p-Akt, p-GSK-3β, and heat shock transcription factor (HSTF-1), and decreases levels of cytosolic cytochrome c, activated caspase 3, and cleaved PARP.

In Vivo: Cilnidipine has potent inhibitory actions on N-type as well as L-type voltage-dependent Ca²⁺-channel in rat dorsal root ganglion neurons.
Administration of Cilnidipine (10 mg/kg) and Nimodipine (10 mg/kg) significantly attenuates the immobilized stress-induced behavioral changes and restored memory deficits along with normalization of the corticosterone levels.
Cilnidipine and Nimodipine produce comparable beneficial effects in restoring immobilization stress subjected mice.
Oral administration of Cilnidipine (3 mg/kg) markedly lowers both systolic and diastolic blood pressure 1 hr after administration in 2K1C renal hypertensive dogs.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Drug Repurposing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Neuroprotective Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Rare Diseases Drug Library  |  Protein-protein Interaction Inhibitor Library  |  Calcium Channel Blocker Library  |  Off-patent Drug Library  |  Mitochondrial Protection Compound Library  |  Antihypertensive Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Mitochondrial Toxicity Compound Library  |  Ion Channel Compound Library  |  Thapsigargin  |  Ionomycin  |  L-Ascorbic acid  |  Minocycline hydrochloride  |  Verapamil  |  2-Aminoethyl diphenylborinate  |  Acetylcholine chloride  |  GSK1016790A  |  Nifedipine  |  Fasudil Hydrochloride  |  Ebselen  |  Halofuginone  |  Tetrandrine  |  Carbamazepine  |  Ruthenium red  |  CDN1163  |  ISX-9  |  Gabapentin  |  TPC2-A1-N  |  Bay K 8644  |  Ethacrynic acid  |  L-Phenylalanine  |  Istaroxime hydrochloride  |  Amlodipine  |  Digitoxin  |  Diltiazem hydrochloride  |  Cromolyn sodium

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds